Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
KOCH KEVIN
President and CEO at Edgewise Therapeutics. Filing since 2 May 2023.
CIK 0001185829
Company
Date
Role
Action
Shares
Amount
Of holding
EWTX
Edgewise Therapeutics, Inc.
12 Aug 2026
President and CEO
Sold at will
17,971
$785.04K
25.5%
EWTX
Edgewise Therapeutics, Inc.
12 Aug 2025
President and CEO
Sold at will
7,972
$106.76K
20.7%
EWTX
Edgewise Therapeutics, Inc.
2 May 2025
President and CEO
Sold at will
4,276
$70.36K
17.2%
EWTX
Edgewise Therapeutics, Inc.
7 Mar 2025
President and CEO
Sold on a plan
100
$3.00K
0.7%
EWTX
Edgewise Therapeutics, Inc.
6 Feb 2025
President and CEO
Sold on a plan
900
$28.02K
5.9%
EWTX
Edgewise Therapeutics, Inc.
5 Feb 2025
President and CEO
Sold on a plan
8,636
$259.30K
37.4%
EWTX
Edgewise Therapeutics, Inc.
2 May 2024
President and CEO
Sold at will
3,152
$59.60K
17.9%
EWTX
Edgewise Therapeutics, Inc.
2 May 2023
President and CEO
Sold at will
3,203
$28.52K
30.8%
8 decisions on file.
